85732-37-2 Usage
Uses
Used in Pharmaceutical Industry:
Spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride serves as a key intermediate in the synthesis of various pharmaceutical agents. Its unique molecular structure allows for the exploration of its potential as a therapeutic agent, particularly in medicinal chemistry and drug development. spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride's ability to be modified and incorporated into new drug molecules makes it valuable for the treatment of a range of medical conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride is utilized as a scaffold for the design and synthesis of new bioactive molecules. Its structural features facilitate the development of compounds with specific biological activities, targeting various disease pathways and offering potential therapeutic benefits.
Used in Drug Development:
Spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride plays a crucial role in drug development, where it is employed as a building block for the creation of innovative pharmaceuticals. Its unique properties and potential interactions with biological targets make it a promising candidate for the discovery of new drugs with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 85732-37-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,7,3 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 85732-37:
(7*8)+(6*5)+(5*7)+(4*3)+(3*2)+(2*3)+(1*7)=152
152 % 10 = 2
So 85732-37-2 is a valid CAS Registry Number.
85732-37-2Relevant academic research and scientific papers
Novel Compounds
-
Page/Page column 61, (2012/04/18)
The present invention relates to the new compounds of general formula I wherein A, U, V, X, Y, R1, R2 and R3 are defined as stated hereinafter, the tautomers, the isomers thereof, the diastereomers, the enantiomers, the hydrates, the mixtures and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, their use and processes for preparing them.
CGRP ANTAGONISTS
-
Page/Page column 29, (2011/08/02)
The present invention relates to novel CGRP antagonists of the general formula (I) in which U, V, X, Y, R1, R2, R3 are defined as described below, the tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts thereof, and the hydrates of the salts, particularly the physiologically compatible salts thereof having inorganic or organic acids or bases, pharmaceuticals comprising said compounds, the use thereof, and the method for the production thereof.
Spiropiperidines. I. Synthesis of 1'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one derivatives and evaluation of their antihypertensive activity
Takai,Obase,Teranishi,Karasawa,Kubo,Shuto,Kasuya,Hashikami,Karashima,Shigenobu
, p. 1129 - 1139 (2007/10/02)
General synthetic methods for the preparation of 4-(2-aminophenyl)-4-hydroxypiperidine derivatives have been developed. The application use of these derivatives in the synthesis of 1'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one derivati
